ad image

Company Info

LabCorp

LabCorp

Other

Overview

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostics solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11.5 billion in 2019.
LabCorp
Contributions
11 Contributions1 / 1
LabCorp
Announcement

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans

LabCorp

PR-02-25-NI-24Feb 25, 2025
LabCorp
H5 Bird Flu Test

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

LabCorp

PR-12-24-NI-140Dec 17, 2024
LabCorp
Diagnostic

LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season

LabCorp

PR-M09-20-NI-13Sep 09, 2020
LabCorp
Clinical Study

LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution

LabCorp

PR-M07-20-NI-003Jul 03, 2020
LabCorp
Leadership

LabCorp Announces New Leadership Roles for Its Two Business Segments and Selects New Chief Human Resources Office

LabCorp

PR-M10-19-NI-015Oct 10, 2019
LabCorp
R&D

Covance Unveils New R&D Center in Shanghai

LabCorp

PR-M09-19-NI-038Sep 16, 2019
LabCorp
Artificial Intelligence

LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

LabCorp

PR-M06-19-NI-050Jun 26, 2019
LabCorp
Oncology

LabCorp Announces Availability of New QIAGEN therascreen FGFR mutation analysis companion diagnostic for Bladder Cancer

LabCorp

PR-M05-19-NI-042May 15, 2019
LabCorp
Collaboration

LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma

LabCorp

PR-M06-18-NI-025Jun 07, 2018
LabCorp
Collaboration

LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency

LabCorp

PR-M05-18-NI-018May 04, 2018
LabCorp

Covance Enters into Strategic Technology Agreement with GSK

LabCorp

PR-M03-18-NI-014Mar 05, 2018
1 / 1
0 Contributors1 / 0

No authors found

1 / 0